Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa

Abstract Background Methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa are becoming difficult to treat with antibiotics whereas Cationic Antimicrobial Peptides (CAMPs) represent promising alternatives. The effects of four CAMPs (LL-37: human cathelicidin, CAMA...

Full description

Bibliographic Details
Main Authors: Regina Geitani, Carole Ayoub Moubareck, Lhousseine Touqui, Dolla Karam Sarkis
Format: Article
Language:English
Published: BMC 2019-03-01
Series:BMC Microbiology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12866-019-1416-8
_version_ 1818509717163474944
author Regina Geitani
Carole Ayoub Moubareck
Lhousseine Touqui
Dolla Karam Sarkis
author_facet Regina Geitani
Carole Ayoub Moubareck
Lhousseine Touqui
Dolla Karam Sarkis
author_sort Regina Geitani
collection DOAJ
description Abstract Background Methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa are becoming difficult to treat with antibiotics whereas Cationic Antimicrobial Peptides (CAMPs) represent promising alternatives. The effects of four CAMPs (LL-37: human cathelicidin, CAMA: cecropin(1–7)-melittin A(2–9) amide, magainin-II and nisin) were investigated against clinical and laboratory S. aureus (n = 10) and P. aeruginosa (n = 11) isolates either susceptible or resistant to antibiotics. Minimal Inhibitory Concentrations (MICs), Minimal Bactericidal Concentrations (MBCs), and bacterial survival rates (2 h post-treatment) were determined by microbroth dilution. The antipseudomonal effects of the antibiotics colistin or imipenem combined to LL-37 or CAMA were also studied. The toxicity of CAMPs used alone and in combination with antibiotics was evaluated on two human lung epithelial cell lines by determining the quantity of released cytoplasmic lactate dehydrogenase (LDH). Attempts to induce bacterial resistance to gentamicin, LL-37 or CAMA were also performed. Results The results revealed the rapid antibacterial effect of LL-37 and CAMA against both antibiotic susceptible and resistant strains with almost a total reduction in bacterial count 2 h post-treatment. Magainin-II and nisin were less active against tested strains. When antibiotics were combined with LL-37 or CAMA, MICs of colistin decreased up to eight-fold and MICs of imipenem decreased up to four-fold. Cytotoxicity assays revealed non-significant LDH-release suggesting no cell damage in all experiments. Induction of bacterial resistance to LL-37 was transient, tardive and much lower than that to gentamicin and induction of resistance to CAMA was not observed. Conclusion This study showed the potent and rapid antibacterial activity of CAMPs on both laboratory and clinical isolates of S. aureus and P. aeruginosa either susceptible or resistant to antibiotics. Most importantly, CAMPs synergized the efficacy of antibiotics, had non toxic effects on human cells and were associated with transient and low levels of induced resistance.
first_indexed 2024-12-10T22:49:14Z
format Article
id doaj.art-0020c4c997ee41fe873fb2f8f6780aa7
institution Directory Open Access Journal
issn 1471-2180
language English
last_indexed 2024-12-10T22:49:14Z
publishDate 2019-03-01
publisher BMC
record_format Article
series BMC Microbiology
spelling doaj.art-0020c4c997ee41fe873fb2f8f6780aa72022-12-22T01:30:29ZengBMCBMC Microbiology1471-21802019-03-0119111210.1186/s12866-019-1416-8Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosaRegina Geitani0Carole Ayoub Moubareck1Lhousseine Touqui2Dolla Karam Sarkis3Microbiology Laboratory, School of Pharmacy, Saint Joseph UniversityMicrobiology Laboratory, School of Pharmacy, Saint Joseph UniversityUnité de Mucoviscidose et Bronchopathies Chroniques, Institut Pasteur/Faculté de Médecine CochinMicrobiology Laboratory, School of Pharmacy, Saint Joseph UniversityAbstract Background Methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa are becoming difficult to treat with antibiotics whereas Cationic Antimicrobial Peptides (CAMPs) represent promising alternatives. The effects of four CAMPs (LL-37: human cathelicidin, CAMA: cecropin(1–7)-melittin A(2–9) amide, magainin-II and nisin) were investigated against clinical and laboratory S. aureus (n = 10) and P. aeruginosa (n = 11) isolates either susceptible or resistant to antibiotics. Minimal Inhibitory Concentrations (MICs), Minimal Bactericidal Concentrations (MBCs), and bacterial survival rates (2 h post-treatment) were determined by microbroth dilution. The antipseudomonal effects of the antibiotics colistin or imipenem combined to LL-37 or CAMA were also studied. The toxicity of CAMPs used alone and in combination with antibiotics was evaluated on two human lung epithelial cell lines by determining the quantity of released cytoplasmic lactate dehydrogenase (LDH). Attempts to induce bacterial resistance to gentamicin, LL-37 or CAMA were also performed. Results The results revealed the rapid antibacterial effect of LL-37 and CAMA against both antibiotic susceptible and resistant strains with almost a total reduction in bacterial count 2 h post-treatment. Magainin-II and nisin were less active against tested strains. When antibiotics were combined with LL-37 or CAMA, MICs of colistin decreased up to eight-fold and MICs of imipenem decreased up to four-fold. Cytotoxicity assays revealed non-significant LDH-release suggesting no cell damage in all experiments. Induction of bacterial resistance to LL-37 was transient, tardive and much lower than that to gentamicin and induction of resistance to CAMA was not observed. Conclusion This study showed the potent and rapid antibacterial activity of CAMPs on both laboratory and clinical isolates of S. aureus and P. aeruginosa either susceptible or resistant to antibiotics. Most importantly, CAMPs synergized the efficacy of antibiotics, had non toxic effects on human cells and were associated with transient and low levels of induced resistance.http://link.springer.com/article/10.1186/s12866-019-1416-8Methicillin-resistant Staphylococcus aureusMultidrug-resistant Pseudomonas aeruginosaCationic antimicrobial peptidesAlternative to antibiotics
spellingShingle Regina Geitani
Carole Ayoub Moubareck
Lhousseine Touqui
Dolla Karam Sarkis
Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa
BMC Microbiology
Methicillin-resistant Staphylococcus aureus
Multidrug-resistant Pseudomonas aeruginosa
Cationic antimicrobial peptides
Alternative to antibiotics
title Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa
title_full Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa
title_fullStr Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa
title_full_unstemmed Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa
title_short Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa
title_sort cationic antimicrobial peptides alternatives and or adjuvants to antibiotics active against methicillin resistant staphylococcus aureus and multidrug resistant pseudomonas aeruginosa
topic Methicillin-resistant Staphylococcus aureus
Multidrug-resistant Pseudomonas aeruginosa
Cationic antimicrobial peptides
Alternative to antibiotics
url http://link.springer.com/article/10.1186/s12866-019-1416-8
work_keys_str_mv AT reginageitani cationicantimicrobialpeptidesalternativesandoradjuvantstoantibioticsactiveagainstmethicillinresistantstaphylococcusaureusandmultidrugresistantpseudomonasaeruginosa
AT caroleayoubmoubareck cationicantimicrobialpeptidesalternativesandoradjuvantstoantibioticsactiveagainstmethicillinresistantstaphylococcusaureusandmultidrugresistantpseudomonasaeruginosa
AT lhousseinetouqui cationicantimicrobialpeptidesalternativesandoradjuvantstoantibioticsactiveagainstmethicillinresistantstaphylococcusaureusandmultidrugresistantpseudomonasaeruginosa
AT dollakaramsarkis cationicantimicrobialpeptidesalternativesandoradjuvantstoantibioticsactiveagainstmethicillinresistantstaphylococcusaureusandmultidrugresistantpseudomonasaeruginosa